Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
Biomedical Materials (Bristol, England)
|
August 9, 2022
Hybrid fibroin/polyurethane small-diameter vascular grafts: from fabrication to<i>in vivo</i>preliminary assessment
Alice Caldiroli, Elia Pederzani, Marco Pezzotta, et al.
Advanced Healthcare Materials
|
September 11, 2020
A Novel Hybrid Silk Fibroin/Polyurethane Arteriovenous Graft for Hemodialysis: Proof-of-Concept Animal Study in an Ovine Model
Stefania Adele Riboldi, Matteo Tozzi, Mara Bagardi, et al.
Kidney International
|
May 30, 2013
Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients
Anna Caroli, Simone Manini, Luca Antiga, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 8, 2023
Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial
Matias Trillini, Anna Caroli, Norberto Perico, et al.
The American Journal of Pathology
|
October 29, 2013
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells
Marina Figliuzzi, Roberto Bianchi, Cristina Cavagnini, et al.
Frontiers in Cardiovascular Medicine
|
August 30, 2023
COVID-19 teleassistance and teleconsultation: a matched case-control study (MIRATO project, Lombardy, Italy)
Palmira Bernocchi, Giacomo Crotti, Elvira Beato, et al.
Lancet (London, England)
|
August 27, 2013
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
Anna Caroli, Norberto Perico, Annalisa Perna, et al.
Plos Medicine
|
April 6, 2019
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial
Norberto Perico, Piero Ruggenenti, Annalisa Perna, et al.
Experimental Neurology
|
November 17, 2016
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy
Marianna Monfrini, Elisabetta Donzelli, Virginia Rodriguez-Menendez, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 26, 2016
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4
Piero Ruggenenti, Giorgio Gentile, Norberto Perico, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
Biomedical Materials (Bristol, England)
|
August 9, 2022
Hybrid fibroin/polyurethane small-diameter vascular grafts: from fabrication to<i>in vivo</i>preliminary assessment
Alice Caldiroli, Elia Pederzani, Marco Pezzotta, et al.
Advanced Healthcare Materials
|
September 11, 2020
A Novel Hybrid Silk Fibroin/Polyurethane Arteriovenous Graft for Hemodialysis: Proof-of-Concept Animal Study in an Ovine Model
Stefania Adele Riboldi, Matteo Tozzi, Mara Bagardi, et al.
Kidney International
|
May 30, 2013
Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients
Anna Caroli, Simone Manini, Luca Antiga, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 8, 2023
Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial
Matias Trillini, Anna Caroli, Norberto Perico, et al.
The American Journal of Pathology
|
October 29, 2013
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells
Marina Figliuzzi, Roberto Bianchi, Cristina Cavagnini, et al.
Frontiers in Cardiovascular Medicine
|
August 30, 2023
COVID-19 teleassistance and teleconsultation: a matched case-control study (MIRATO project, Lombardy, Italy)
Palmira Bernocchi, Giacomo Crotti, Elvira Beato, et al.
Lancet (London, England)
|
August 27, 2013
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
Anna Caroli, Norberto Perico, Annalisa Perna, et al.
Plos Medicine
|
April 6, 2019
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial
Norberto Perico, Piero Ruggenenti, Annalisa Perna, et al.
Experimental Neurology
|
November 17, 2016
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy
Marianna Monfrini, Elisabetta Donzelli, Virginia Rodriguez-Menendez, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 26, 2016
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4
Piero Ruggenenti, Giorgio Gentile, Norberto Perico, et al.
Page
of 15